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Abstract
The ubiquitin associated and Src-homology 3 (SH3) domain containing A (UBASH3a) is a suppressor of T-cell receptor
signaling, underscoring antigen presentation to T-cells as a critical shared mechanism of diseases pathogenesis. The aim of
the present study was to determine whether the UBASH3a gene influence the susceptibility to systemic lupus
erythematosus (SLE) in Caucasian populations. We evaluated five UBASH3a polymorphisms (rs2277798, rs2277800,
rs9976767, rs13048049 and rs17114930), using TaqManH allelic discrimination assays, in a discovery cohort that included
906 SLE patients and 1165 healthy controls from Spain. The SNPs that exhibit statistical significance difference were
evaluated in a German replication cohort of 360 SLE patients and 379 healthy controls. The case-control analysis in the
Spanish population showed a significant association between the rs9976767 and SLE (Pc = 9.9E-03 OR= 1.21 95%CI = 1.07–
1.37) and a trend of association for the rs2277798 analysis (P = 0.09 OR= 0.9 95%CI = 0.79–1.02). The replication in a German
cohort and the meta-analysis confirmed that the rs9976767 (Pc = 0.02; Pc = 2.4E-04, for German cohort and meta-analysis,
respectively) and rs2277798 (Pc = 0.013; Pc = 4.7E-03, for German cohort and meta-analysis, respectively) UBASH3a variants
are susceptibility factors for SLE. Finally, a conditional regression analysis suggested that the most likely genetic variation
responsible for the association was the rs9976767 polymorphism. Our results suggest that UBASH3a gene plays a role in the
susceptibility to SLE. Moreover, our study indicates that UBASH3a can be considered as a common genetic factor in
autoimmune diseases.
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Introduction
The T cell ubiquitin ligand proteins (TULA) family is
characterized by function as suppressors of T cell receptor
signalling. One of the members of the TULA family proteins is
the ubiquitin associated and Src-homology 3 (SH3) domain
containing A (UBASH3a) which is expressed only in lymphoid cells
and facilitates apoptosis induced in T cells by certain stimuli, such
as growth factor withdrawal [1]. UBASH3a gene spans 40 kb,
contains 15 exons and is located on human chromosome 21q22.3
[2]. The lack of TULA proteins resulted in hyper-reactivity of T
cells [1]. Evidence for both B and T lymphocyte hyper-reactivity is
typically observed in autoimmune disorders [2]. These disorders
are characterized by an inappropriate, ultimately excessive,
inflammatory response against self, resulting in tissue destruction.
Although many individuals affected by autoimmune diseases
demonstrate multiorgan involvement, the primary end-organ
target (e.g., autoimmune destruction of pancreatic islet cells in
type 1 diabetes mellitus) typically drives the clinical presentation
and disease definition. Recent studies have showed that single
nucleotide polymorphisms (SNPs) of the UBASH3a gene are
associated with some autoimmune diseases, like type 1 diabetes
(T1D), celiac disease (CD), rheumatoid arthritis (RA) and vitiligo,
suggesting that this gene could play an important role in the
pathogenesis of autoimmune disorders [3–8].
Systemic lupus erythematosus (SLE) is a prototypic autoimmune
diseases characterized by the production of autoantibodies,
immune-complex deposition, and subsequent multiple organ
damage. The complex aetiology of autoimmune diseases includes
environmental, hormonal and genetic factors. Some of those
factors remained to be defined [3,4]. Based on these insights, the
aim of the present study was to evaluate the role of five UBASH3a
polymorphism in SLE.
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e60646
Materials and Methods
Ethics Statement
Written informed consent was obtained from all participants
and the respectively ethics committee approved the study
according to the principles expressed in the Declaration of
Helsinki.
The case-control study included 906 SLE patients and 1165
healthy controls from a white Spanish population. The replication
cohort from white Germans comprehends 360 SLE patients and
379 healthy controls. All the patients met the American College of
Rheumatology criteria for classification of SLE [5]. Written
informed consent was obtained from all participants and the
respectively ethics committee approved the study. DNA was
obtained from peripheral blood using standard methods. The
samples were genotyped for the UBASH3a rs2277798, rs2277800,
rs9976767, rs13048049 and rs17114930 polymorphisms via
TaqManH 59allelic discrimination technology using a predesigned
SNPs genotyping assays provided by Applied Biosystems (assay ID:
C___1724055_10, C__15885522_20, C___1724067_10,
C___1724073_20 and C___25622591_10, respectively; Figure
S1). At the moment of the design of the study the only confirmed
case-control associated SNP with autoimmune diseases was the
rs9976767 [6]. The other four SNPs were selected because they
were not included in previous SLE genetic studies and they are
non-synonymous changes located in different exons of the
UBASH3a gene. Moreover, the minor allele frequency (MAF) of
those SNPs was reported in Caucasian populations and they
exhibited moderated LD with at least one SNP in the loci.
Deviation from Hardy-Weinberg equilibrium (HWE) was tested
by standard chi-square analysis. The differences in genotype
distribution and allele frequency among cases and controls were
calculated by contingency tables and when necessary by Fisher’s
exact test. Odds ratios (OR), and 95% confidence intervals (CI),
were calculated according to Woolf’s method. Combined data
were analysed by Mantel-Haenszel tests under fixed effect model
and the Breslow-Day (BD) test was used to estimate the OR
heterogeneity amongst the two cohorts. An association was
considered statistically significant if P,0.05. Benjamini & Hoch-
berg (1995) step-up false discovery rate (FDR) control correction
Table 1. Genotype and minor allele frequencies of UBASH3a SNPs located in Caucasian SLE patients and healthy controls from
Spain, the discovery cohort.
Genotype, N (%) Alleles, N(%) Allele test
SNP 1/2 Subgroup (N) 1/1 1/2 2/2 1 2 P-value* OR [CI 95%]****
rs2277798 G/A Controls (n = 1165) 477 (40.94) 529 (45.41) 159 (13.65) 1483 (63.6) 847 (36.4)
SLE (n = 906) 402 (44.37) 394 (43.49) 110 (12.14) 1198 (66.1) 614 (33.9) 0.0993** 0.90 [0.79-1.02]
rs2277800 C/T Controls (n = 1165) 1080 (92.70) 84 (7.21) 1 (0.09) 2244 (96.3) 86 (3.7)
SLE (n = 906) 832 (91.83) 73 (8.06) 1 (0.11) 1737 (95.9) 75 (4.1) 0.4592 1.13 [0.82–1.55]
rs9976767 A/G Controls (n = 1165) 363 (31.16) 558 (47.90) 244 (20.94) 1284 (55.1) 1046 (44.9)
SLE (n = 906) 230 (25.39) 451 (49.78) 225 (24.83) 911 (503) 901 (49.7) 1.99E-03*** 1.21 [1.07–1.37]
rs13048049 G/A Controls (n = 1165) 1038 (89.10) 126 (10.82) 1 (0.09) 2202 (94.5) 128 (5.5)
SLE (n = 906) 808 (89.18) 96 (10.60) 2 (0.22) 1712 (94.5) 100 (5.5) 0.9719 1.01 [0.77–1.32]
rs17114930 C/G Controls (n = 1165) 1066 (91.50) 95 (8.15) 4 (0.34) 2227 (95.6) 103 (4.4)
SLE (n = 906) 811 (89.51) 93 (10.26) 2 (0.22) 1715 (94.6) 97 (5.4) 0.1649 1.22 [0.92–1.63]
*All P-values have been calculated for the allelic model. ** Pc = 0.248 Benjamini & Hochberg (1995). ***Pc = 9.9E-03 Benjamini & Hochberg (1995) step-up FDR control.
****Odds ratio for the minor allele.
doi:10.1371/journal.pone.0060646.t001
Figure 1. Graphical representation of the meta-analysis (A) Forest plot for the meta-analysis of the UBASH3a rs2277798
polymorphism in SLE in two Caucasian cohorts. (B) Forest plot for the meta-analysis of the UBASH3a rs9976767 polymorphism in SLE in two
Caucasian cohorts.
doi:10.1371/journal.pone.0060646.g001
UBASH3A & SLE
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[7] for multiple testing was applied to the P-values in both the
independent analysis and the combined meta-analysis (Pc).
Linkage disequilibrium (LD) measurement (r2) between the studied
SNPs was estimated by expectation-maximization algorithm using
HAPLOVIEW (version 4.2; Broad Institute of MIT and Harvard).
Finally, the dependency of the association between each SNP and
every studied genetic variant was determined by a conditional
logistic regression analysis (considering the different cohorts as
covariate). The analyses were performed using PLINK (version
1.07) [8].
Results
The distributions of genotypic and allelic frequencies of the five
UABSH3a evaluated polymorphisms were in HWE at 5%
significance level. Additionally, MAFs of the studied SNPs were
similar to those reported by the HapMap project for the CEU
population (http://hapmap.ncbi.nlm.nih.gov/) in both, Spanish
and German cohorts. The LD structure of the five UABSH3a SNPs
in the Spanish cohort is shown in (Figure S1). The Table 1
summarizes the results of the association analysis for the discovery
cohort. The minor allele of the rs9976767 polymorphism
exhibited a statistical significant association with SLE in the
Spanish population (Pc = 9.9E-03, OR = 1.21, 95%CI = 1.07–
1.37). In addition we observed a trend of association with the
rs2277798 polymorphism (P = 0.099, Pc = 0.248, OR = 0.9,
95%CI = 0.79–1.02). The frequency of the minor alleles of the
rs2277800, rs13048049 and rs17114930 UBASH3a polymor-
phisms were not statistically significantly different between SLE
patients and healthy controls in the Spanish cohort.
Based on these observations, we evaluated the frequency of the
rs9976767 and rs2277798 in a replication cohort from Germany
(Table 2). Genotypic and allelic frequencies of both polymor-
phisms were in HWE. The frequency of the minor allele of both
SNPs: rs9976767 and rs2277798 were statistically significant
different between SLE patients and healthy controls: rs9976767
(Pc = 0.02, OR = 1.28 95%CI = 1.04–1.57) and rs227798
(Pc = 0.01, OR = 0.75, 95%CI = 0.6–0.92). Lastly, we combine
both the Spanish and German cohorts through a meta-analysis in
order to increase the statistical power and to determine the
combine OR (Table 3 and Figure 1). This analysis showed
evidence of association of the minor allele of rs9976767 with
higher SLE risk (Pc = 4.7E-03, OR = 1.23 95%CI = 1.11–1.37)
and the rs2277798 with lower risk to SLE (Pc = 2.4–04,
OR = 0.85, 95%CI = 0.76–0.95).
Finally, we prompted out to evaluate whether one of both
polymorphisms is responsible for the associations detected using a
logistic regression analysis. Pair-wise conditional analysis showed
that the association of the rs2277798 SNP was explained by the
rs9976767effect, because only the coefficient for the test of
rs9976767 remained significant (model conditioned by
rs2277798P = 0.76; model conditioned by rs9976767 P = 9E-03,
Table 4).
Discussion
UBASH3a is implicated in the regulation of tyrosine phosphor-
ylation levels within T cells and is involved in facilitates the
apoptosis induced in these cells. UBASH3a binds to the apoptosis-
inducing protein AIF, which has previously been shown to
function as a key factor of caspase-independent apoptosis [9]. It
has also been reported that SLE T cells, compared with control T
cells, undergo an increased rate of apoptosis, which contribute to
SLE pathogenesis [4]. Changes in the UBASH3a structure or
expression levels can affect the binding with AIF leading to an
alteration in the apoptosis level.
Herein, we described for the first time the influence of five
UBASH3a genetic variants in SLE susceptibility. Interestingly, the
Table 2. Genotype and minor allele frequencies of UBASH3a SNPs located in Caucasian SLE patients and healthy controls from
Germany.
Genotype, N (%) Alleles, N(%) Allele test
SNP K Subgroup (N) 1/1 1/2 2/2 1 2 P-value* PFR** OR [CI 95%]***
rs2277798 G/A Controls (n = 379) 184 (48.55) 132 (34.83) 63 (16.62) 448 (59.1) 310 (40.9)
SLE(n = 360) 149 (41.39) 163 (45.28) 48 (13.33) 475 (66) 245 (34) 0.0064 0,0128 0.75 [0.60–0.92]
rs9976767 A/G Controls (n = 379) 186 (49.08) 136 (35.88) 57 (15.04) 458 (60.4) 300 (39.4)
SSc (n = 360) 180 (50.00) 106 (29.44) 74 (20.56) 392 (54.4) 328 (45.6) 0.0201 0,0201 1.28 [1.04–1.57]
*All P-values have been calculated for the allelic model. ** Benjamini & Hochberg (1995) step-up FDR control. ***Odds ratio for the minor allele.
doi:10.1371/journal.pone.0060646.t002
Table 3. Meta-analysis of two UBASH3a genetic variants within Spanish and German SLE populations.
Genotype, N (%) Alleles, N(%) Allele test
SNP
K
Subgroup (N) 1/1 1/2 2/2 1 2 P-value* PFDR** OR [CI 95%]***
rs2277798 G/A Controls (n = 1544) 609 (39.44) 713 (46.18) 222 (14.38) 1931 (62.5) 1157 (37.5)
SLE (n = 1266) 565 (44.63) 543 (42.89) 158 (12.48) 1673 (66.1) 859 (33.9) 0.0047 4.7E-03 0.85 [0.76–0.95]
rs9976767 A/G Controls (n = 1544) 499 (32.32) 744 (48.19) 301 (19.49) 1742 (56.4) 13446 (43.6)
SLE (n = 1266) 336 (26.54) 631 (49.84) 299 (23.62) 1303 (51.5) 1229 (48.5) 1.2E-04 2,4E-04 1.23 [1.11–1.37]
*All P-values have been calculated for the allelic model. **Benjamini & Hochberg (1995) step-up FDR control. ***Odds ratio for the minor allele.
doi:10.1371/journal.pone.0060646.t003
UBASH3A & SLE
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rs9976767 polymorphism is located in the intronic region between
the exons 5 and 6 while the other four studied SNPs (rs2277798,
rs2277800, rs13048049 and rs17114930) are non-synonymous
changes located in three different exons. The intronic regions
flanking constitutive exons contain potential splicing regulatory
sequences. Moreover, a study restricted to analysis of the canonical
splice signals reported that 15% of point mutations disrupted
splicing, a likely gross underestimate of the impact of splicing on
human disease [10]. This suggests that the rs9976767 polymor-
phism could be affecting the expression of different UBASH3a
isoforms consequently affecting the binding to AIF. Concerning to
this we checked if there is any relation between the rs9976767 and
expression of UBASH3a gene using expression quantitative trait
loci (eQTL) databases. Interesting, there is a significant statistical
correlation between the increase of UBASH3a expression in
lymphoblastoid cell lines and the homozygotes for the minor
allele of rs9976767 (rho = 0.483, P = 1.3E-05; Figure S2A) in one
of the two groups of twins studied (this observation was done using
Genevar 3.2.0 software) [11,12]. Furthermore the eQTL studies in
asthma showed that the SNPs (rs9784215, rs3746923, rs2277797)
with highest LOD score (LOD.4.5, P,1E-05) in the UBAHS3a
locus are in moderate to high LD with rs9976767 (Figure S2B and
C; this observation was done using mRNA by SNP Browser 1.0.1
http://www.sph.umich.edu/csg/liang/asthma/) [13,14]. This ev-
idence suggested that rs9976767 could have a functional role in
the regulation of the expression of UBASH3a. However, and
according with HapMap project (http://hapmap.ncbi.nlm.nih.
gov/), this SNP tags other six variants in this region (rs7278547,
rs11702374, rs9976479, rs3746924, rs3761378, rs7283281;
r2.0.95) and considering the present study and the previous
GWAS [15,16] we have studied approximately 15% of the genetic
variation of UBASH3a locus. In order to cover all the genetic
variation of this gene, it is necessary to genotype 181 SNPs
(calculated through an aggressive tagging with 2-marker haplo-
types in Haploview 4.2 software using CEPH population from
HapMap project). All these together suggest that the rs9976767 is
a good functional candidate risk factor to SLE, but it could be
more than one variant related to SLE.
No previous reports have associated the rs9976767 UBASH3a
polymorphism with SLE. Nevertheless, it is worth noting that the
rs9976767 SNP or its six tags variants were not included in
previous genome wide association studies (GWAS) in Caucasian
SLE cohorts [15,16]. Although the statistical power is 96% for our
meta-analysis (calculate using a p value = 0.05:OR = 1.2:
MAF = 0.4), the results found in our study should be replicated
in different Caucasian cohorts and other populations. Furthermore
there is a need to determine whether the statistical associations are
related with the involvement of UBASH3a in the pathogenesis of
SLE and other autoimmune diseases. Regarding to this, the
UBASH3a gene seems to be a common genetic factor in
autoimmune diseases because different polymorphism of this locus
has been associated with autoimmune diseases like T1D, CD, RA
and vitiligo [6,17–21]. Our results showed that the minor allele of
the rs9976767 UBASH3a polymorphism is a risk factor to SLE, as
similarly observed with T1D [6]. Nevertheless, there is no
evidence of association between this variant and other autoim-
mune diseases. This can be linked with the suggestion that
common genetic factors in autoimmune diseases could match a
regional level but differ in the specific genetic variant associated to
each disease, like the associations observed with IL2–IL21 and
MHC loci [22]. Based on the concept of quantitative thresholds
for immune-cell signalling, the effect of the rs976767 UBAHS3a
variant could diversely affect the range of values for the stimulus-
response selection of the immune cells in different autoimmune
pathologies, making it more or less relevant in different diseases
[3].
In conclusion, our study showed the first evidence of association
of the UBASH3a gene with the genetic background of SLE.
Together the functional role of the protein encoded by this gene,
the reported data in the eQTLs databases and our results point to
the UBASH3a gene as a new element in the pathogenic mechanism
of autoimmune diseases.
Supporting Information
Figure S1 Pattern of linkage disequilibrium of the five
studied SNPs and their location in the UBAHS3a gene.
The values correspond to r2 calculated for the Spanish cohort.
The rs2277798 polymorphism [G/A] is located in exon 1 of
UBASH3a gene. It’s a no-synonymous change in the position 18 of
the protein (S[Ser]/G[Gly]). The rs2277800 polymorphism [C/T]
is also located in exon 1 of UBASH3a gene and generate a change
in the position 28 of the protein (L[Leu]/F[Phe]). In the other
hand, the rs9976767 [A/G] is an intronic variant located between
the exons 5 and 6 of the UBASH3a gene. Both variants rs13048049
[G/A] and rs17114930 [C/G] are no-synonymous changes in
exons 7 and 11, respectively. The first one produce a change from
arginine (R[Arg]) to glutamine (Q[Gln]) in position 286; while the
rs17114930 polymorphism generates a change from aspartic acid
(D[Asp]) to glutamic acid (E[Glu]) in position 428 in Caucasian
population.
(TIF)
Figure S2 Results observed using different expression
quantitative trait loci (eQTL) tools to evaluate if there is any
relationship between the rs9976767 variant and the UBASH3a
expression (A) SNP-gene association plot for the rs9976767
and the UBASH3a gene based on Spearman’s rank correlation
coefficient (rho) using the Genevar 3.2 software (http://www.
sanger.ac.uk/resources/software/genevar/) [1]. The eQTL anal-
ysis was performed in lymphoblastoid cell lines from peripheral
Table 4. Conditional logistic regression analysis for two UBASH3a SNPs located in SLE considering the two European populations
as covariate.
Group of analysis SNP MAF Cases MAF Controls
p Value: add
to rs9976767
rs9976767 p
value: add to
SNP r2 with rs9976767
Spain Germany
SLE
rs2277798 0.34 0.38 0.758 0.0087 0.45 0.41
doi:10.1371/journal.pone.0060646.t004
UBASH3A & SLE
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blood sample (n = 74). The plot corresponds to one of the two
twins groups studied [2]. (B) Linkage disequilibrium (LD)
plot performed in Haploview 4.2 [3]. LD plot between rs9976767
and the rs9784215, rs3746923, rs2277797 SNPs which exhibited
the highest LOD score (LOD.4.5, P,1E-05) in the UBAHS3a
locus showed in (C) Snapshot of observed eQTLs related
with UBASH3a gene from the mRNA by SNP Browser 1.0.1
software (http://www.sph.umich.edu/csg/liang/asthma/) based
on eQTL studies in asthma [4,5]. The LOD scores and P values
for those SNPs are: rs9784215, LOD = 4.909 P = 2E-06;
rs3746923, LOD = 4.905 P = 2E-06; rs2277797, LOD = 4.68
P = 3.4E-06. They are signalled as red dots in the LOD plot. 1.
Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-
Arcelus M, et al. (2010) Genevar: a database and Java application
for the analysis and visualization of SNP-gene associations in
eQTL studies. Bioinformatics 26: 2474-2476. 2. Nica AC, Parts L,
Glass D, Nisbet J, Barrett A, et al. (2011) The architecture of gene
regulatory variation across multiple human tissues: the MuTHER
study. PLoS Genet 7: e1002003. 3. Barrett JC, Fry B, Maller J,
Daly MJ (2005) Haploview: analysis and visualization of LD and
haplotype maps. Bioinformatics 21: 263-265. 4. Dixon AL, Liang
L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide
association study of global gene expression. Nat Genet 39: 1202-
1207. 5. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan
D, et al. (2007) Genetic variants regulating ORMDL3 expression
contribute to the risk of childhood asthma. Nature 448: 470-473.
(TIF)
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